Management of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia: What is the Best Strategy?
Volume: 26, Issue: 9, Pages: e237 - e238
Published: Sep 1, 2020
Abstract
We read the study recently reported by Schmidt et al [1Schmidt S Liu Y Hu ZH et al.The role of donor lymphocyte infusion (DLI) in post-hematopoietic cell transplant (HCT) relapse for chronic myeloid leukemia (CML) in the tyrosine kinase inhibitor (TKI) era.Biol Blood Marrow Transplant. 2020; (26:P1137-P1143)Abstract Full Text Full Text PDF PubMed Scopus (9) Google Scholar] with great interest, in which they retrospectively analyzed 215 patients...
Paper Details
Title
Management of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia: What is the Best Strategy?
Published Date
Sep 1, 2020
Volume
26
Issue
9
Pages
e237 - e238
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History